Matinas Biopharma Holdings, Inc. (MTNB) Social Stream
MATINAS BIOPHARMA HOLDINGS INC (MTNB) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering MTNB.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 4 | $3 | $2 | $2.666 | $0.229 | 1064.19% |
| 2022-03-09 | 3 | $3 | $2 | $2.666 | $0.229 | 1064.19% |
| 2022-05-23 | 2 | $3 | $2 | $2.5 | $0.229 | 991.7% |
| 2022-11-03 | 4 | $3.5 | $2 | $2.875 | $0.229 | 1155.46% |
| 2023-03-29 | 1 | $2 | $1.5 | $1.75 | $0.229 | 664.19% |
| 2023-10-12 | 1 | $3 | $1.5 | $2.25 | $0.229 | 882.53% |
| 2023-10-13 | 2 | $3 | $0.3 | $1.65 | $0.229 | 620.52% |
The Trend in the Analyst Price Target
MTNB's average price target has moved down $1.18 over the prior 49 weeks.
MTNB reports an average of 485.96% for its upside potential over the past 30 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-29 | 1 | 2.0 | 1.5 | 1.750 | 0.455 | 284.62% |
| 2023-03-29 | 2 | 3.5 | 1.5 | 2.333 | 0.455 | 412.75% |
| 2023-03-29 | 3 | 3.5 | 1.5 | 2.333 | 0.455 | 412.75% |
| 2023-10-12 | 1 | 3.0 | 1.5 | 2.250 | 0.252 | 792.86% |
| 2023-10-13 | 2 | 3.0 | 0.3 | 1.650 | 0.211 | 681.99% |
MTNB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
MTNB's average broker recommendation rating improved by 0 over the prior 31 weeks.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- To contextualize these metrics, consider that out of all US stocks, MATINAS BIOPHARMA HOLDINGS INC's average analyst price target is greater than 12.47% of them.
- To contextualize these metrics, consider that out of all US stocks, MATINAS BIOPHARMA HOLDINGS INC's upside potential (average analyst target price relative to current price) is greater than 1161.88% of them.
- MATINAS BIOPHARMA HOLDINGS INC's number of analysts covering the stock is higher than 75.15% of Healthcare stocks.
- To contextualize these metrics, consider that out of Pharmaceutical Products stocks, MATINAS BIOPHARMA HOLDINGS INC's variance in analysts' estimates is lower than -376.02% of them.
Stocks similar to MATINAS BIOPHARMA HOLDINGS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ORMP, FBRX, and BYSI.
View All Top Stocks by Price Target
Make investment decisions regarding MTNB using the data that counts. Try POWR Ratings for free.